According to a new report from Intel Market Research, the global Psychobiotic Supplements market was valued at USD 1.15 billion in 2025 and is projected to grow from USD 1.27 billion in 2026 to USD 2.95 billion by 2034, growing at a robust CAGR of 11.0% during the forecast period (2026–2034). This growth is propelled by heightened awareness of the gut-brain axis, surging prevalence of...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek